Recent Advances in Drug Discovery and Cancer Diagnoses

Author:

Zhang Jian1,Chai Haiting2

Affiliation:

1. School of Computer and Information Technology, Xinyang Normal University, Xinyang, China

2. College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom

Abstract

This editorial provides a brief overview of the thematic issue and the papers in it. The thematic issue is proposed to help chemists and biologists track the most recent advances in drug discovery and cancer diagnoses. The process of drug discovery involves the identification and validation of biological targets, the identification and optimization of lead compounds, preclinical development, and clinical trials. Cancer is a major public health problem in the world. The results of tissue diagnosis, blood tests, computed tomography scans, and cytogenetic analyses can provide informative clues about molecular changes and indicate proper prognoses. Timely detection of cancer significantly improves cancer outcomes by providing care at the earliest possible stage thus contributing greatly to the prevention and exacerbation and has become an important public health strategy in all settings. The collection of this thematic issue includes five articles. The first one reviews the current advances and limitations of deep learning in anticancer drug sensitivity prediction. The next review summarizes the most recent and high-quality research related to anticancer activities of Vitamin C. The third one reports the efficacy of two different sets of natural products (terpenoids and flavonoids) towards caspase-3 activity. The fourth one proposes a novel in silico method for predicting cancer biomarkers in human body fluids. The fifth article performs an in silico and in vitro investigation on isothymusin, which serves as a potential inhibitor of cancer cell proliferation.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,General Medicine

Reference15 articles.

1. D'Agostino V.G.; Sighel D.; Zucal C.; Bonomo I.; Micaelli M.; Lolli G.; Provenzani A.; Quattrone A.; Adami V.; Screening approaches for targeting ribonucleoprotein complexes: a new dimension for drug discovery. SLAS Discovery : Advancing Life Sciences R 2019,24(3),314-331

2. Singh S.S.; Preclinical pharmacokinetics: an approach towards safer and efficacious drugs. Curr Drug Metab 2006,7(2),165-182

3. Nayal M.; Honig B.; On the nature of cavities on protein surfaces: application to the identification of drug-binding sites. Proteins 2006,63(4),892-906

4. Vaquero-Garcia J.; Barrera A.; Gazzara M.R.; Gonzalez-Vallinas J.; Lahens N.F.; Hogenesch J.B.; Lynch K.W.; Barash Y.; A new view of transcriptome complexity and regulation through the lens of local splicing variations. eLife 2016,5

5. Shi L.; Campbell G.; Jones W.D.; Campagne F.; Wen Z.; Walker S.J.; Su Z.; Chu T.M.; Goodsaid F.M.; Pusztai L.; Shaughnessy J.D.; Oberthuer A.; Thomas R.S.; Paules R.S.; Fielden M.; Barlogie B.; Chen W.; Du P.; Fischer M.; Furlanello C.; Gallas B.D.; Ge X.; Megherbi D.B.; Symmans W.F.; Wang M.D.; Zhang J.; Bitter H.; Brors B.; Bushel P.R.; Bylesjo M.; Chen M.; Cheng J.; Cheng J.; Chou J.; Davison T.S.; Delorenzi M.; Deng Y.; Devanarayan V.; Dix D.J.; Dopazo J.; Dorff K.C.; Elloumi F.; Fan J.; Fan S.; Fan X.; Fang H.; Gonzaludo N.; Hess K.R.; Hong H.; Huan J.; Irizarry R.A.; Judson R.; Juraeva D.; Lababidi S.; Lambert C.G.; Li L.; Li Y.; Li Z.; Lin S.M.; Liu G.; Lobenhofer E.K.; Luo J.; Luo W.; McCall M.N.; Nikolsky Y.; Pennello G.A.; Perkins R.G.; Philip R.; Popovici V.; Price N.D.; Qian F.; Scherer A.; Shi T.; Shi W.; Sung J.; Thierry-Mieg D.; Thierry-Mieg J.; Thodima V.; Trygg J.; Vishnuvajjala L.; Wang S.J.; Wu J.; Wu Y.; Xie Q.; Yousef W.A.; Zhang L.; Zhang X.; Zhong S.; Zhou Y.; Zhu S.; Arasappan D.; Bao W.; Lucas A.B.; Berthold F.; Brennan R.J.; Buness A.; Catalano J.G.; Chang C.; Chen R.; Cheng Y.; Cui J.; Czika W.; Demichelis F.; Deng X.; Dosymbekov D.; Eils R.; Feng Y.; Fostel J.; Fulmer-Smentek S.; Fuscoe J.C.; Gatto L.; Ge W.; Goldstein D.R.; Guo L.; Halbert D.N.; Han J.; Harris S.C.; Hatzis C.; Herman D.; Huang J.; Jensen R.V.; Jiang R.; Johnson C.D.; Jurman G.; Kahlert Y.; Khuder S.A.; Kohl M.; Li J.; Li L.; Li M.; Li Q.Z.; Li S.; Li Z.; Liu J.; Liu Y.; Liu Z.; Meng L.; Madera M.; Martinez-Murillo F.; Medina I.; Meehan J.; Miclaus K.; Moffitt R.A.; Montaner D.; Mukherjee P.; Mulligan G.J.; Neville P.; Nikolskaya T.; Ning B.; Page G.P.; Parker J.; Parry R.M.; Peng X.; Peterson R.L.; Phan J.H.; Quanz B.; Ren Y.; Riccadonna S.; Roter A.H.; Samuelson F.W.; Schumacher M.M.; Shambaugh J.D.; Shi Q.; Shippy R.; Si S.; Smalter A.; Sotiriou C.; Soukup M.; Staedtler F.; Steiner G.; Stokes T.H.; Sun Q.; Tan P.Y.; Tang R.; Tezak Z.; Thorn B.; Tsyganova M.; Turpaz Y.; Vega S.C.; Visintainer R.; von Frese J.; Wang C.; Wang E.; Wang J.; Wang W.; Westermann F.; Willey J.C.; Woods M.; Wu S.; Xiao N.; Xu J.; Xu L.; Yang L.; Zeng X.; Zhang J.; Zhang L.; Zhang M.; Zhao C.; Puri R.K.; Scherf U.; Tong W.; Wolfinger R.D.; The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol 2010,28(8),827-838

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3